Kalia Anderson, Lynn B Gerald, Elizabeth Hall-Lipsy, Kathryn McCulley, Elizabeth Vuong, Hanna Phan
{"title":"Pharmacists' perspectives on school stock inhaler access for children.","authors":"Kalia Anderson, Lynn B Gerald, Elizabeth Hall-Lipsy, Kathryn McCulley, Elizabeth Vuong, Hanna Phan","doi":"10.1057/s41271-023-00423-8","DOIUrl":null,"url":null,"abstract":"<p><p>Several states in the United States (U.S.) have laws permitting stock inhalers, including short-acting beta-agonist inhalers, such as albuterol, and spacers to be prescribed to, dispensed to, and stocked in schools for use in students in respiratory distress, based on a protocol. This survey study assessed Arizona pharmacists' (1) levels of comfort for dispensing a short-acting beta-agonist inhaler to an individual child versus a stock inhaler to a school, and (2) awareness of the related Arizona state law. Researchers surveyed pharmacists licensed in Arizona who self-reported practicing in an outpatient pharmacy setting. Among 251 pharmacist participants, 62% practiced in a chain community pharmacy. About 80.8% felt comfortable filling a prescription for an albuterol inhaler in a pediatric patient case, whereas only 26.7% felt comfortable filling a prescription for albuterol inhalers to be used as stock inhalers for a given school. Among those who would not fill the stock inhaler prescription, only 5.5% reported awareness of the state law compared to 42.6% of those who would fill it (p < 0.0001). This survey identified a lack of pharmacist awareness of state laws pertaining to stock inhalers for schools.</p>","PeriodicalId":50070,"journal":{"name":"Journal of Public Health Policy","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Public Health Policy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1057/s41271-023-00423-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/21 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Several states in the United States (U.S.) have laws permitting stock inhalers, including short-acting beta-agonist inhalers, such as albuterol, and spacers to be prescribed to, dispensed to, and stocked in schools for use in students in respiratory distress, based on a protocol. This survey study assessed Arizona pharmacists' (1) levels of comfort for dispensing a short-acting beta-agonist inhaler to an individual child versus a stock inhaler to a school, and (2) awareness of the related Arizona state law. Researchers surveyed pharmacists licensed in Arizona who self-reported practicing in an outpatient pharmacy setting. Among 251 pharmacist participants, 62% practiced in a chain community pharmacy. About 80.8% felt comfortable filling a prescription for an albuterol inhaler in a pediatric patient case, whereas only 26.7% felt comfortable filling a prescription for albuterol inhalers to be used as stock inhalers for a given school. Among those who would not fill the stock inhaler prescription, only 5.5% reported awareness of the state law compared to 42.6% of those who would fill it (p < 0.0001). This survey identified a lack of pharmacist awareness of state laws pertaining to stock inhalers for schools.
期刊介绍:
The Journal of Public Health Policy (JPHP) will continue its 35 year tradition: an accessible source of scholarly articles on the epidemiologic and social foundations of public health policy, rigorously edited, and progressive.
JPHP aims to create a more inclusive public health policy dialogue, within nations and among them. It broadens public health policy debates beyond the ''health system'' to examine all forces and environments that impinge on the health of populations. It provides an exciting platform for airing controversy and framing policy debates - honing policies to solve new problems and unresolved old ones.
JPHP welcomes unsolicited original scientific and policy contributions on all public health topics. New authors are particularly encouraged to enter debates about how to improve the health of populations and reduce health disparities.